Literature DB >> 9765409

Human cytotoxic T-lymphocyte repertoire to influenza A viruses.

J Jameson1, J Cruz, F A Ennis.   

Abstract

The murine CD8(+) cytotoxic-T-lymphocyte (CTL) repertoire appears to be quite limited in response to influenza A viruses. The CTL responses to influenza A virus in humans were examined to determine if the CTL repertoire is also very limited. Bulk cultures revealed that a number of virus proteins were recognized in CTL assays. CTL lines were isolated from three donors for detailed study and found to be specific for epitopes on numerous influenza A viral proteins. Eight distinct CD8(+) CTL lines were isolated from donor 1. The proteins recognized by these cell lines included the nucleoprotein (NP), matrix protein (M1), nonstructural protein 1 (NS1), polymerases (PB1 and PB2), and hemagglutinin (HA). Two CD4(+) cell lines, one specific for neuraminidase (NA) and the other specific for M1, were also characterized. These CTL results were confirmed by precursor frequency analysis of peptide-specific gamma interferon-producing cells detected by ELISPOT. The epitopes recognized by 6 of these 10 cell lines have not been previously described; 8 of the 10 cell lines were cross-reactive to subtype H1N1, H2N2, and H3N2 viruses, 1 cell line was cross-reactive to subtypes H1N1 and H2N2, and 1 cell line was subtype H1N1 specific. A broad CTL repertoire was detected in the two other donors, and cell lines specific for the NP, NA, HA, M1, NS1, and M2 viral proteins were isolated. These findings indicate that the human memory CTL response to influenza A virus is broadly directed to epitopes on a wide variety of proteins, unlike the limited response observed following infection of mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765409      PMCID: PMC110281     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone.

Authors:  K Kuwano; M Tamura; F A Ennis
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

2.  Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule.

Authors:  G M Van Bleek; S G Nathenson
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

3.  Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition.

Authors:  L R Brown; N R Nygard; M B Graham; C Bono; V L Braciale; J Gorka; B D Schwartz; T J Braciale
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

4.  CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68.1.

Authors:  V Cerundolo; A G Tse; R D Salter; P Parham; A Townsend
Journal:  Proc Biol Sci       Date:  1991-05-22       Impact factor: 5.349

5.  Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus.

Authors:  K L Yap; G L Ada; I F McKenzie
Journal:  Nature       Date:  1978-05-18       Impact factor: 49.962

6.  Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity.

Authors:  H J Zweerink; B A Askonas; D Millican; S A Courtneidge; J J Skehel
Journal:  Eur J Immunol       Date:  1977-09       Impact factor: 5.532

7.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

8.  Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.

Authors:  S Huet; D F Nixon; J B Rothbard; A Townsend; S A Ellis; A J McMichael
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

9.  Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes.

Authors:  J F Bukowski; I Kurane; C J Lai; M Bray; B Falgout; F A Ennis
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

10.  Antigenic drift in type A influenza virus: peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal antibodies.

Authors:  W G Laver; W Gerhard; R G Webster; M E Frankel; G M Air
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

View more
  78 in total

1.  Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Authors:  J T Voeten; T M Bestebroer; N J Nieuwkoop; R A Fouchier; A D Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Depletion of human NK and CD8 cells prior to in vitro H1N1 flu vaccine stimulation increases the number of gamma interferon-secreting cells compared to the initial undepleted population in an ELISPOT assay.

Authors:  Christophe Dercamp; Violette Sanchez; Julie Barrier; Emanuelle Trannoy; Bruno Guy
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

3.  Variability of NS1 proteins among H9N2 avian influenza viruses isolated in Israel during 2000-2009.

Authors:  A Panshin; N Golender; I Davidson; S Nagar; M Garsia; M W Jackwood; E Mundt; A Alturi; S Perk
Journal:  Virus Genes       Date:  2010-08-19       Impact factor: 2.332

4.  Repeated influenza vaccination of healthy children and adults: borrow now, pay later?

Authors:  F Carrat; A Lavenu; S Cauchemez; S Deleger
Journal:  Epidemiol Infect       Date:  2006-02       Impact factor: 2.451

Review 5.  The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

Authors:  Jindrich Cinatl; Martin Michaelis; Hans W Doerr
Journal:  Med Microbiol Immunol       Date:  2007-06-01       Impact factor: 3.402

6.  Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine.

Authors:  Mary Dawn T Co; Laura Orphin; John Cruz; Pamela Pazoles; Alan L Rothman; Francis A Ennis; Masanori Terajima
Journal:  Vaccine       Date:  2008-02-26       Impact factor: 3.641

Review 7.  Immunobiology of influenza vaccines.

Authors:  Margarita M Gomez Lorenzo; Matthew J Fenton
Journal:  Chest       Date:  2013-02-01       Impact factor: 9.410

8.  Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice.

Authors:  Leo L M Poon; Y H Connie Leung; John M Nicholls; Pin-Yu Perera; Jack H Lichy; Masafumi Yamamoto; Thomas A Waldmann; J S Malik Peiris; Liyanage P Perera
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity.

Authors:  Alessandro Sette; John Sidney; Huynh-Hoa Bui; Marie-France del Guercio; Jeff Alexander; John Loffredo; David I Watkins; Bianca R Mothé
Journal:  Immunogenetics       Date:  2005-03-04       Impact factor: 2.846

10.  Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination.

Authors:  Yu-Na Lee; Young-Tae Lee; Min-Chul Kim; Hye Suk Hwang; Jong Seok Lee; Ki-Hye Kim; Sang-Moo Kang
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.